Common Contracts
2 similar Underwriting Agreement contracts by Luxurban Hotels Inc., Medgenics, Inc.
LUXURBAN HOTELS INC. UNDERWRITING AGREEMENT 30,000,000 Shares of Common StockUnderwriting Agreement • July 12th, 2024 • Luxurban Hotels Inc. • Real estate • New York
LuxUrban Hotels Inc., a Delaware corporation (the “Company”‘), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters.” or each, an “Underwriter”), for whom Alexander Capital, L.P., is acting as the representative (the “Representative”). 30,000,000 authorized but unissued shares (the “Firm Shares”) of common stock of the Company, par value $0.00001 per share (the “Common Stock”) and 0 Pre-Funded Warrants, each to purchase one share of Common Stock at an exercise price of $0.01 per share (“Firm Pre-Funded Warrants”). In addition, the Company also proposes to sell to the Underwriters, upon the terms and conditions set forth in Section 4 hereof, up to an additional 4,500,000 authorized but unissued shares of Common Stock (the “Option Shares”) and/or up to an additional 0 Pre-Funded Warrants (the “Option Pre-Funded Warrants”. The Firm Shares and the Option Shares are hereinafter collectively referred
● Shares ● Warrants MEDGENICS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • February 22nd, 2011 • Medgenics, Inc. • Biological products, (no disgnostic substances) • California
Medgenics, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters”) for whom Roth Capital Partners, LLC is acting as representative (the "Representative"), an aggregate of (i) ● authorized but unissued shares (the “Firm Shares”) of Common Stock, par value $0.0001 per share (the “Common Stock”), of the Company and (ii) warrants (the "Firm Warrants") to purchase up to ● shares of Common Stock of the Company (the "Firm Warrant Shares"). The Company has granted the Underwriters the option to purchase an aggregate of up to (i) ● Option Shares of Common Stock (the “Option Shares”) and (ii) Option Warrants (the "Option Warrants") to purchase up to ● shares of Common Stock of the Company (the "Option Warrant Shares" and together with the Firm Warrant Shares, the "Warrant Shares") as may be necessary to cover over-allotments made in connection with the offering
